로딩 중…
지수 로딩 중…
Novartis AG
NVS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$140.36-0.40%
2026-09-18
Financials
Valuation Metrics
Novartis AG's Market Cap is $267.82B. At end of 2025 it was $263.75B. Ranked #48 of 3,121 in US market (top 2%), #26 of 1,658 on NYSE (top 2%), #5 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 2%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $267.82B | US#48/3,121 Sec#5/266 |
| Revenue | $55.63B | US#115/3,121 Sec#7/266 |
| Net Income | $12.76B | US#45/3,121 Sec#4/266 |
| Total Assets | $122.03B | US#145/3,121 Sec#7/266 |
| Net Assets | $41.54B | US#107/3,121 Sec#7/266 |
| Employees | 75,267 | US#170/3,121 Sec#4/266 |
| Value | ||
| P/E | 20.99x | US#1,193/3,121 Sec#34/266 |
| P/B | 6.45x | US#2,397/3,121 Sec#165/266 |
| P/S | 4.81x | US#2,268/3,121 Sec#73/266 |
| EV/EBITDA | 13.89x | US#1,414/3,121 Sec#38/266 |
| FCF Yield | 5.91% | US#1,231/3,121 Sec#38/266 |
| Profitability | ||
| ROE | 30.71% | US#285/3,121 Sec#16/266 |
| ROA | 10.46% | US#453/3,121 Sec#33/266 |
| Op. Margin | 30.54% | US#509/3,121 Sec#25/266 |
| Revenue Growth | 0.81% | US#2,185/3,121 Sec#130/266 |
| Earnings Growth | -6.55% | US#1,409/3,121 Sec#36/266 |
| Financial Health | ||
| Debt Ratio | 192.79% | US#1,757/3,121 Sec#198/266 |
| Total Debt | $49.01B | US#93/3,121 Sec#7/266 |
| FCF | $15.82B | US#47/3,121 Sec#5/266 |
| Cash | $7.62B | US#138/3,121 Sec#5/266 |
| Current Ratio | 0.86x | US#2,435/3,121 Sec#263/266 |
| Net Debt/EBITDA | 1.86x | US#1,275/3,121 Sec#55/266 |
| Dividend | ||
| Div. Yield | 3.40% | US#528/3,121 Sec#9/266 |
| Div. Growth | 3.07% | US#973/3,121 Sec#15/266 |
| Performance | ||
| 1Y Return | 14.78% | US#1,315/3,121 Sec#163/266 |
| 1M Return | -12.44% | US#2,312/3,121 Sec#173/266 |
| From 52W High | -17.66% | US#1,305/3,121 Sec#90/266 |
| 1Y MDD | -18.66% | US#604/3,121 Sec#21/266 |
| Trading | ||
| Volume | 1,520,080 shares | US#1,175/3,121 Sec#118/266 |
| Trading Value | $213M | US#504/3,121 Sec#29/266 |
| Per Share | ||
| EPS | $6.69 | US#493/3,121 Sec#15/266 |
| BPS | $21.77 | US#1,159/3,121 Sec#25/266 |
Company Info
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.